Trial Profile
Retrospective, Multicenter, Open-Label Study of of Anakinra in Refractory Adult-Onset Still´S Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2015
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Adult-onset Still's disease
- Focus Therapeutic Use
- 19 Jun 2015 New trial record